ENOCHIAN BIOSCIENCES, INC.

(ENOB)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

ENOCHIAN BIOSCIENCES INC : Regulation FD Disclosure (form 8-K)

12/22/2021 | 04:20pm EDT

Item 7.01. Regulation FD Disclosure.

Enochian BioSciences Inc., a Delaware corporation (the "Company") today made available an investor presentation (the "Investor Presentation"). The Investor Presentation is attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference.

The information included in this Item 7.01 and in Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

The Company undertakes no duty or obligation to update or revise information included in this Report or the Exhibit.

© Edgar Online, source Glimpses

All news about ENOCHIAN BIOSCIENCES, INC.
05/18ENOCHIAN BIOSCIENCES INC : Other Events (form 8-K)
AQ
05/13Enochian Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
05/13ENOCHIAN BIOSCIENCES INC Management's Discussion and Analysis of Financial Condition a..
AQ
04/20ENOCHIAN BIOSCIENCES : Announces the Appointment of Executive Vice President of Research a..
PU
04/20ENOCHIAN BIOSCIENCES INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
04/20Enochian BioSciences Announces the Appointment of Executive Vice President of Research ..
AQ
04/20Enochian BioSciences Appoints Dr. François Binette, Ph.D. as Executive Vice President f..
CI
04/07ENOCHIAN BIOSCIENCES : Announces Appointment of Senior Vice President for Clinical Operati..
PU
04/07ENOCHIAN BIOSCIENCES INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
04/07Enochian BioSciences Announces Appointment of Senior Vice President for Clinical Operat..
AQ
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -26,7 M - -
Net cash 2021 13,3 M - -
P/E ratio 2021 -8,77x
Yield 2021 -
Capitalization 311 M 311 M -
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees 11
Free-Float 39,1%
Chart ENOCHIAN BIOSCIENCES, INC.
Duration : Period :
Enochian Biosciences, Inc. Technical Analysis Chart | ENOB | US29350E1047 | MarketScreener
Technical analysis trends ENOCHIAN BIOSCIENCES, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers and Directors
Mark Richard Dybul Executive Vice Chairman & Chief Executive Officer
Luisa Puche Chief Financial Officer
Rene Sindlev Chairman
Joseph R. Cohen Director-Research & Discovery
Greg Duczynski Senior Director-Clinical Development & Operations
Sector and Competitors
1st jan.Capi. (M$)
ENOCHIAN BIOSCIENCES, INC.-18.93%311
GILEAD SCIENCES, INC.-12.93%79 298
REGENERON PHARMACEUTICALS, INC.4.38%71 026
VERTEX PHARMACEUTICALS14.91%64 540
WUXI APPTEC CO., LTD.-18.77%41 409
BIONTECH SE-39.08%38 169